hasRouteOfAdministration
P23149
predicate
Indicates that one entity specifies the method or pathway by which another entity (typically a substance or medication) is administered.
Aliases (2)
- routeOfAdministration ×15
- isRouteOfAdministration ×1
Sample triples (38)
| Subject | Object |
|---|---|
| Activase | intravenous ("routeOfAdministration") → |
| Aduhelm | intravenous infusion ("routeOfAdministration") → |
| Avastin | intravenous infusion ("routeOfAdministration") → |
| Darzalex | intravenous infusion → |
| Darzalex | subcutaneous injection → |
| Fampyra | oral → |
| Herceptin | intravenous infusion ("routeOfAdministration") → |
| Imbruvica | oral → |
| Janssen COVID-19 Vaccine | intramuscular injection ("routeOfAdministration") → |
| Leqembi | intravenous infusion → |
| Listerine | topical oral use ("routeOfAdministration") → |
| Lucentis | intravitreal injection → |
| Perjeta | intravenous infusion ("routeOfAdministration") → |
| Plegridy | subcutaneous → |
| Plegridy | subcutaneous injection → |
| Remicade | intravenous infusion → |
| Rituxan | intravenous infusion ("routeOfAdministration") → |
| Spinraza | intrathecal ("routeOfAdministration") → |
| Spinraza | lumbar puncture ("routeOfAdministration") → |
| Stelara | intravenous infusion → |
| Stelara | subcutaneous injection → |
| Tecentriq | intravenous infusion ("routeOfAdministration") → |
| Tecfidera | oral → |
| Tylenol | oral ("routeOfAdministration") → |
| Tylenol | rectal ("routeOfAdministration") → |
| Tysabri | intravenous infusion ("routeOfAdministration") → |
| Vumerity | oral → |
| Xarelto | oral ("isRouteOfAdministration") → |
| Xolair | subcutaneous → |
| Xolair | subcutaneous injection → |
| oseltamivir | oral → |
| oseltamivir | oral capsule → |
| oseltamivir | oral suspension → |
| rVSV-ZEBOV | intramuscular injection ("routeOfAdministration") → |
| zanamivir | inhalation → |
| zanamivir | intranasal → |
| zanamivir | intravenous → |
| zanamivir | oral (investigational, low bioavailability) → |